Clinical Trial Update: Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma [Phase 2]

View source ↗

Summary

Phase 2 neoadjuvant trial evaluating PD-1 blockade in patients with stage IIB/C melanoma is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PD-1 blockade

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Melanoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING